JW THERAP-B

02126

----

Current ValuationThe current P/E ratio is -2.38, within the reasonable range, cheaper than 75.02% of the time in the past 5 years, and the industry ranks 28/78, the industry Median -4.79.

-2.38xP/E

Stock priceHK$2.22Earnings per shareHK$-0.93

Historical Valuation

P/E ratioTypical rangeMedian

Peer P/E ratio Comparison

It displays how the company's P/E ratio compares to top companies within its industry.

0146292438584

The industry median valuation is currently at or below 0 and may not serve as a meaningful benchmark.

Industry P/E ratio Comparison

This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.

0x30x60x90x120x150x

P/E ratio
Name/Symbol
09926HKAKESO	-68.88x	75.55%	HK$76.70B
09688HKZAI LAB	-14.73x	432.84%	HK$21.73B
01877HKJUNSHI BIO	-34.10x	85.34%	HK$15.67B
07666HKMETIS TECHBIO-P	-32.40x	96.71%	HK$13.19B
02627HKAB&B BIO-TECH-B	-46.87x	--	HK$11.54B
06855HKASCENTAGE	-6.03x	18.76%	HK$10.20B
01952HKEVEREST MED	-154.28x	324.72%	HK$9.58B
09606HKDUALITYBIO-B	-5.73x	85.35%	HK$9.49B
02595HKGENFLEET-B	-5.67x	66.07%	HK$8.59B
02493HKMABWELL-B	-6.66x	--	HK$8.14B
02616HKCSTONE PHARMA-B	-16.34x	1.09%	HK$7.89B
09887HKLEADS BIOLABS-B	-23.30x	3.57%	HK$7.16B
06938HKRIBOLIFE-B	-36.29x	29.56%	HK$7.09B
02171HKCARSGEN-B	-61.52x	51.05%	HK$6.32B
09966HKALPHAMAB-B	-29.64x	--	HK$6.00B
01672HKASCLETIS-B	-7.57x	78.53%	HK$5.16B
00775HKCKLIFE SCIENCES	-72.79x	--	HK$4.71B
02256HKABBISKO-B	-8.25x	800.99%	HK$4.43B
02335HKMICOT PHARMA-B	-9.17x	37.52%	HK$3.85B
01779HKLONGBIO-B	-15.35x	--	HK$3.82B

Risk Warning

Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.